However, it is still unclear whether alterations in CSF tau may serve as biomarker for ALS. Objectives. To determine whether there are novel genetic variants in tau and whether CSF tau levels are altered in ALS. Results. We identified specific and unique ALS genetic variants in MAPT through the ALS Knowledge Portal and Project MinE data sets..